Cellebrite DI Ltd. (CLBT)
NEUTRAL基本面
68
价格
$11.50
市值
$2.84B
第一部分 · 这家公司值多少
概览
Cellebrite DI Ltd. develops software and services for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company provides a platform of software solutions used to access, collect, review, extract, decode, decrypt, analyze, share and manage digital evidence across the investigative lifecycle for a range of investigations, such as child exploitation, homicide, anti-terror, border control, sexual crimes, organized crime, human trafficking, corporate security, and intellectual property theft, as well as financial crimes, including those involving cryptocurrency. It also offers Inseyets, digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations; Guardian Forensics, an evidence management solution which enables customers to manage their digital forensics workflows, and to store, share and review digital evidence; Guardian Collaborate, a digital evidence sharing tool; and Guardian Investigate, a case management and AI-powered analytics solution. In addition, it provides Cellebrite Pathfinder, which reduces the time spent manually reviewing digital evidence and enables actionable insights into a range of crime types; Corellium Falcon for conducting mobile vulnerability research, exploit introspection, and malware analysis; and Corellium Viper for mobile application penetration testing capabilities. Further, the company offers professional services, such as training and certification services, and advanced services. It serves federal, state, and local agencies, as well as corporations and service providers. The company is headquartered in Petah Tikva, Israel.
No editorial profile for this company yet
Direct competitors
Who this company fights with for the same customers
No editorial profile for this company yet
No competitor list for this company yet.
资产负债表与流动性
营收
$496M
最近12个月(截至2026/3/31)
净利润
$72M
最近12个月(截至2026/3/31)
自由现金流
$125M
股东权益合计
$538M
负债合计
$23M
流动比率
1.62
利息覆盖率
-
债务/EBITDA
0.30
每股收益
营收与净利润
自由现金流
收入构成
历史财务表
利润率变化
债务变化
债务负担有多重
增长一览表
增长 — 营业收入
公允价值估算
公允价值
$19.57
当前价格
$11.50
安全边际
+41.2%
公允价值区间
$12.72 - $26.42
估算方法
估值指标
市盈率(P/E)
49.22
ROE
12.4%
市净率(P/B)
5.27
P/FCF
22.72
毛利率
83.0%
ROIC
3.8%
盈利能力雷达图
Value Creation (Economic Moat)
ROIC
3.8%
WACC
10.6%
ROIC − WACC
-6.7 pp
ROIC is below the cost of capital — the company is destroying value for every dollar invested.
基本面分析标准
通过(13)
- Gross Margin 83.0%
- P/FCF 22.72
- Debt/Equity ratio
- Positive Free Cash Flow
- Current Ratio
- Debt/EBITDA
- ROE 15.5%
- Revenue Growth 5Y 19.5%
- Analyst Consensus 93% Buy
- Earnings Surprise avg 6.8%
- PEG Ratio 0.63
- Earnings Quality (OCF/NI) 2.01
- Net Margin Trend 16.5% vs -70.5%
未通过(6)
- Price CAGR 0.81%
- ROIC 3.8%
- P/B Ratio 5.27
- CapEx intensity
- DCF valuation (Overvalued)
- Piotroski F-Score 2/9
不可用(8)
- EPS data insufficient
- Dividend Payout NaN%
- Operating Margin NaN%
- Interest Coverage
- Return on Tangible Assets
- Low reliance on intangibles
- Price below Graham Number
- Share Dilution (missing shares data)
Piotroski F-评分
存在严重财务隐患
盈利质量
高质量:盈利有现金流支撑
股权稀释
正在回购股份,对股东友好
公司治理
第二部分 · 价格与买入时机
这一部分不判断公司是否值得拥有:它帮助你在基本面说服你之后,选择何时买入。包含:技术分析、潜力、历史回撤、Gamma 敞口。
Latest News
Recent headlines for CLBT, sourced from Markets Gazette.